Vanderbilt Stimulating Access to Research in Residency (V-StARR)
Vanderbilt Stimulating Access to Research in Residency (V-StARR)
批准号:
10591987
负责人:
STEVEN A. WEBBER
金额:
$37.89万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-01-01 至 2027-12-31
关键词:
Academic Medical CentersAppointmentAptitudeAreaAwardChildhoodClinicalCollaborationsCommunity DevelopmentsCompetenceDevelopment PlansDoctor of PhilosophyEducational workshopEnvironmentEvaluationFacultyFeedbackFellowshipFundingGenerationsGoalsGrantHuman ResourcesInfrastructureInstitutionInternationalInvestigationLocationLongterm Follow-upMedical EducationMedical centerMedicineMentorsMentorshipMinorMissionNational Heart, Lung, and Blood InstituteOutcomePathway interactionsPediatricsPeer ReviewPerformancePhasePositioning AttributeProcessProductivityProgram DevelopmentPublicationsQualifyingRecordsResearchResearch PersonnelResearch Project GrantsResearch TrainingResidenciesResourcesScientistStrategic visionStructureTimeTrainingTraining ProgramsUnderrepresented MinorityUnderrepresented PopulationsUnited States National Institutes of HealthUniversitiesWomancareercareer developmentdiversity and inclusionexpectationexperienceimprovedinterestmedical schoolsmultidisciplinarypopulation healthprogramsrecruitresponsesuccesstenure track
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The goal of this application is to continue the highly successful Vanderbilt - Stimulating Access to Research
in Residency; V-StARR) mentored training program for residents in Medicine or Pediatrics who possess both
the aptitude and passion for becoming a new generation of clinician-scientists. We will continue to focus on “late
bloomers”; typically, those residents who decide to pursue a career as a clinician-scientist after acceptance to a
standard clinical residency pathway. The primary goal is to provide a nurturing mentored environment for
Resident Investigators to perform highly rigorous research training to facilitate a successful transition to a
research-focused fellowship and subsequent appointment as tenure track faculty. The overarching goal is to
expand the pipeline of those achieving independence as clinician-scientists. Another core goal is to promote
diversity and inclusion in research training in a highly intentional way. Each Resident Investigator will develop
and complete a mentored research project in an area of focus consistent with the missions of NHLBI and will
also participate in selected workshops and courses and in our clinician-scientist development communities.
Investigation may be basic, translational, clinical, or population health. All of our R38 graduates have gone on to
pursue research-based careers and based on their success, and our deep applicant pool, we are expanding our
program to six training slots to support Resident Investigators for 1-2 years with a minimum of 80% protected
research time. Four of these slots will be funded by the R38 award and one slot each by the Departments of
Medicine and Pediatrics. There is a formal program selection process to identify the most competitive applicants.
Our proven success in recruitment to the program demonstrates our ability to attract a strong group of applicants.
The program will provide intense scientific mentorship and personalized career development. The Resident
Investigators will have access to a cadre of more than fifty carefully selected NIH-funded preceptors who have
successful track records of mentoring early career scholars. Each Resident Investigator will have a personalized
Scholarly Oversight Committee to assist them in achieving program goals, to evaluate resident progress, and to
develop, advise on, and track their career development plan. Evaluation of Resident Investigators includes
competency-based milestone assessments. There will be equally rigorous program assessments. Key outcomes
for the program include: Academic productivity (presentations, peer-review publications, grants); recruitment of
scholars from diverse backgrounds; entry of residents into research intensive fellowships; and success in
obtaining T32 positions and K38 grants. Long-term follow-up of all Resident Investigators will be performed using
Flight Tracker and through personal contact. The Departments of Medicine and Pediatrics are fully integrated
into the Vanderbilt School of Medicine and Medical Center, and both rank in the top 10 in NIH funding. There
exists a very strong relationship between the Departments and between the PIs. We have incorporated several
important changes into this successful program and believe that these will further strengthen the V-StARR.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chronic Graft Destruction: Interplay of Allo- and Autoantibodies and Nonadherence
-
批准号:9590743
-
项目类别:
-
资助金额:$39.64万
-
财政年份:2018
-
负责人:STEVEN A. WEBBER
-
依托单位:
Vanderbilt Stimulating Access to Research in Residency (V-StARR)
-
批准号:10201735
-
项目类别:
-
资助金额:$32.2万
-
财政年份:2018
-
负责人:STEVEN A. WEBBER
-
依托单位:
Pathogenesis, Targeted Therapeutics, and New Vaccines for Childhood Disease
-
批准号:9217660
-
项目类别:
-
资助金额:$34.57万
-
财政年份:2016
-
负责人:STEVEN A. WEBBER
-
依托单位:
Pathogenesis, Targeted Therapeutics, and New Vaccines for Childhood Disease
-
批准号:10372216
-
项目类别:
-
资助金额:$44.0万
-
财政年份:2016
-
负责人:STEVEN A. WEBBER
-
依托单位:
Pathogenesis, Targeted Therapeutics, and New Vaccines for Childhood Disease
-
批准号:10225917
-
项目类别:
-
资助金额:$44.0万
-
财政年份:2016
-
负责人:STEVEN A. WEBBER
-
依托单位:
Chronic Graft Destruction: Interplay of Allo- and Autoantibodies and Nonadherence
-
批准号:8466120
-
项目类别:
-
资助金额:$117.42万
-
财政年份:2013
-
负责人:STEVEN A. WEBBER
-
依托单位:
Chronic Graft Destruction: Interplay of Allo- and Autoantibodies and Nonadherence
-
批准号:8606403
-
项目类别:
-
资助金额:$84.55万
-
财政年份:2013
-
负责人:STEVEN A. WEBBER
-
依托单位:
Chronic Graft Destruction: Interplay of Allo- and Autoantibodies and Nonadherence
-
批准号:8996113
-
项目类别:
-
资助金额:$14.64万
-
财政年份:2013
-
负责人:STEVEN A. WEBBER
-
依托单位:
Alloantibodies in Cardiac Transplantation - Intervention, Outcomes and Mechanisms
-
批准号:8034232
-
项目类别:
-
资助金额:$113.68万
-
财政年份:2008
-
负责人:STEVEN A. WEBBER
-
依托单位:
Alloantibodies in Cardiac Transplantation - Intervention, Outcomes and Mechanisms
-
批准号:7914250
-
项目类别:
-
资助金额:$120.26万
-
财政年份:2008
-
负责人:STEVEN A. WEBBER
-
依托单位:
Alloantibodies in Cardiac Transplantation - Intervention, Outcomes and Mechanisms
-
批准号:7451546
-
项目类别:
-
资助金额:$115.19万
-
财政年份:2008
-
负责人:STEVEN A. WEBBER
-
依托单位:
Alloantibodies in Cardiac Transplantation - Intervention, Outcomes and Mechanisms
-
批准号:8265871
-
项目类别:
-
资助金额:$54.76万
-
财政年份:2008
-
负责人:STEVEN A. WEBBER
-
依托单位:
Alloantibodies in Cardiac Transplantation - Intervention, Outcomes and Mechanisms
-
批准号:7575219
-
项目类别:
-
资助金额:$121.09万
-
财政年份:2008
-
负责人:STEVEN A. WEBBER
-
依托单位:
Alloantibodies in Cardiac Transplantation - Intervention, Outcomes and Mechanisms
-
批准号:8590939
-
项目类别:
-
资助金额:$59.32万
-
财政年份:2008
-
负责人:STEVEN A. WEBBER
-
依托单位:
Optimizing Outcome After Pediatric Heart Transplantation
-
批准号:6854545
-
项目类别:
-
资助金额:$278.24万
-
财政年份:2004
-
负责人:STEVEN A. WEBBER
-
依托单位:
Optimizing Outcome After Pediatric Heart Transplantation
-
批准号:7189873
-
项目类别:
-
资助金额:$212.31万
-
财政年份:2004
-
负责人:STEVEN A. WEBBER
-
依托单位:
Optimizing Outcome After Pediatric Heart Transplantation
-
批准号:6698906
-
项目类别:
-
资助金额:$282.63万
-
财政年份:2004
-
负责人:STEVEN A. WEBBER
-
依托单位:
Optimizing Outcome After Pediatric Heart Transplantation
-
批准号:7344815
-
项目类别:
-
资助金额:$203.26万
-
财政年份:2004
-
负责人:STEVEN A. WEBBER
-
依托单位:
Thymic Tolerance in Pediatric Heart Transplantation
-
批准号:6772507
-
项目类别:
-
资助金额:$25.93万
-
财政年份:2004
-
负责人:STEVEN A. WEBBER
-
依托单位:
Optimizing Outcome After Pediatric Heart Transplantation
-
批准号:7046076
-
项目类别:
-
资助金额:$243.77万
-
财政年份:2004
-
负责人:STEVEN A. WEBBER
-
依托单位:
海外基金